Bringing Gene Therapy to the Fight Against Lung Cancers Registration

Start Date:10/27/2023

Start Time:12:30 PM EDT

Duration:75 minutes

Abstract:

Genprex cordially invites you to join us for a Key Opinion Leader virtual event to learn more about its novel gene therapy for lung cancer.

If you're already registered for the Bringing Gene Therapy to the Fight Against Lung Cancers webcast, click below:

ALREADY REGISTERED?

Speakers

Mark S. Berger, M.D.

Chief Medical Officer

Genprex

Dr. Berger is a senior executive with 25 years of biotech and pharmaceutical company experience in the development of oncology therapeutics. Prior to joining Genprex, Dr. Berger served as Chief Medical Officer for Actinium Pharmaceuticals.

Alexander I. Spira, M.D., PhD, FACP

Co-Director

VCS Research Institute

Dr. Alexander Spira is a medical oncologist specialized in the treatment of lung cancer. Dr. Spira serves as the Director of the Virginia Cancer Specialists (VCS) Research Institute.

Daniel Morgensztern, M.D.

Professor of Medicine, Division of Oncology, Section of Medical Oncology

Washington University School of Medicine

Dr. Daniel Morgensztern is a medical oncologist specialized in the treatment of lung and esophageal cancer. Dr. Morgensztern serves as a Professor of Medicine, and Director of Thoracic Oncology at Washington University School of Medicine.